Angio Suites - Market Insights, Competitive Landscape, and Market Forecast - 2030

The Angio Suites market is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing cases of chronic disorders and the rising product developmental activities worldwide.

The angio suites market was valued at USD 2.18 billion in 2023, growing at a CAGR of 5.75% during the forecast period from 2024 to 2030 to reach USD 3.05 billion by 2030. The angio suites market is observing substantial market growth primarily owing to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation, peripheral artery disease (PAD), and coronary artery disease (CAD), innovative product developmental activities by leading companies, and the rising geriatric population that are expected to escalate the overall growth of the angio suites market during the forecast period from 2024 to 2030.

Angio Suites Market Dynamics:

As per data provided by the World Heart Report (2023), in 2021 it was stated that more than half a billion people were living with cardiovascular diseases globally. Further, according to recent data provided by the American Heart Association (2023), it is estimated that by 2030 over 12 million people will have atrial fibrillation globally.

According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people are living with CAD around the world.

As per data by the American Heart Association (2023), around 200 million live with PAD globally on average. Also, as per the Global Burden of Disease (2019), there were 56.4 million prevalent cases of PAD among those aged 40 to 70, worldwide in 2019.

Angio suites are vital for diagnosing and treating cardiovascular diseases like CAD, PAD, and atrial fibrillation. Moreover, angio suites can be used for catheter-based procedures like atrial fibrillation ablation to restore normal heart rhythm.

Another prominent factor responsible for the growth of the angio suites market is the constant technological developments taking place in the angio suites market for product design, and for increasing its safety and precision. For instance, in October 2021, Yashoda Hospitals, located in Secunderabad, India launched a 'Bi-Plane Neuro Angio Procedure Suite' with DTAS (Direct to Angio Suite) technology used for providing quick and highly advanced treatment in cases of brain stroke and neurological emergencies such as heart attacks.

Increased product developmental activities by regulatory bodies worldwide is also slated to witness market growth for angio suites. For example in May 2022, Philips announced FDA 510(k) clearance for its new MR 7700 3.0T MR system, giving high performance and precision for both research and advanced clinical diagnostics.

Therefore, all the factors stated above collectively will drive the overall angio suites market growth.

However, side effects such as infections, hematoma, vessel injuries, lack of skilled workforce and medical infrastructure, and others may prove to be challenging factors for the angio suites market growth.

Angio Suites Market Segment Analysis:

Angio Suites Market by Type (Single-Plane and Bi-Plane), Application (Angiography, Angioplasty, Stenting, Bypass Surgery, and Others), and Geography (North-America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of angio suites market, the stenting category is expected to have a significant revenue share in the year 2023. This can be ascribed to an increase in stenting procedures around the world, required in acute cases of stroke, rising prevalence of stroke cases globally, leading to serious consequences like disability and death, this segment of the angio suites market is expected to generate considerable revenue.
Furthermore, technological advancements and product innovations taking place in the development of wearable angio suites are likely to propel the angio suites market growth. For instance, in June 2022, Siemens Healthineers, launched the Angiography System Artis Icono, for various applications like stenting, stroke diagnosis and treatment and others. It is enabled with new system mechanics and image chains for 2D and 3D imaging with seamless integration and a third-party interface.

Angio suites designed for stenting procedures feature advanced imaging technologies, specialized catheterization tools, and patient monitoring systems. They are primarily used to treat CAD and PAD by placing stents to keep narrowed or blocked arteries open, thus improving blood flow and reducing the risk of heart attacks. These suites also facilitate emergency interventions for acute coronary syndromes, ensuring timely cardiovascular care.

Therefore, the widespread uses and various key features offered by stenting category, that enhance performance and usability are solidifying the impact on the growth of the overall angio suites market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall angio suites market:

Among all the regions, North America is expected to dominate the angio suites market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to several factors including the high prevalence of CAD and other heart conditions, along with associated risk factors for cardiovascular disorders, combined with significant advancements in product development and regulatory approvals that are acting as key factors contributing to the growth of the angio suites market in the North America region during the forecast period from 2024 to 2030.

As per data provided by the National Institute of Health (2023), it stated that 20.5 million people in the US were living with CAD. Furthermore, according to data from the Centers for Disease Control and Prevention (2024), it was stated that 805,000 people in the US have a myocardial infarction (heart attack) every year on average. Furthermore, as per the same source, it was stated that heart disease is an umbrella term that encompasses numerous indications such as acute coronary syndrome, atherosclerosis, and congestive heart failure among others.

Data from the Canadian Institute for Health Information (2024), stated that in 2022, 2.4 million Canadians were affected by heart disease. Also, according to the American Health Association (2022), Canada stands the second most to be affected by stroke globally in the year 2021.

Angio suites enable crucial diagnostic procedures like angiography to visualize coronary arteries and identify blockages. For myocardial infarction, angio suites facilitate interventions such as angioplasty and stenting to restore blood flow to the heart. Their versatility also allows for the treatment of various heart conditions, ensuring timely diagnosis and effective care.

Rising product developmental activities by regulatory bodies in the region will further boost the market for angio suites. For example, in March 2022, Philips received 510(k) market clearance from the U.S. Food & Drug Administration (FDA) for its angio suite Philips Capsule Surveillance solution, paving the way for widespread deployment across healthcare systems in the US. The angio suite is capable of utilizing streaming data from virtually any connected medical device and helps in the analysis to generate actionable insights and alerts.

Additionally, in June 2022, Canon Medical Systems decided to collaborate with The Harley Street Healthcare Group Canada to launch a group of innovative diagnostic centers across Ontario. The diagnostic center is said to possess a highly equipped Angiography suite with the latest X-ray generators, Molecular Imaging, Ultrasound, and Healthcare Informatics.

Therefore, the presence of a large patient population base with heart disorders, coupled with a rise in regulatory approvals for angio suites is expected to bolster the growth of the angio suites market in the North American region during the forecast period.

Angio Suites Market key players:

Some of the key market players operating in the angio suites market include Siemens Healthineers, Koninklijke Philips N.V, Lam Vascular and Associates, Hitachi, Ltd., ESAOTE SPA, IMRIS, Onex Corporation, Canon Inc., 3D Systems, Inc., GE HealthCare, Shimadzu Corporation, GIMIAS, FUJIFILM Holdings Corporation, Hologic, Inc., Planmeca, Mindray Medical International Limited, ZEISS International, Guerbet, Surgical Science, B.Braun Melsungen AG, and others.

Recent Developmental Activities in the Angio Suites Market:

• In June 2022, Siemens Healthineers, launched the Angiography System Artis Icono, for precise tumor embolization. It is enabled with new system mechanics and image chains for 2D and 3D imaging with seamless integration and a third-party interface.
• In December 2021, GE Healthcare, an auxiliary company of well-known Massachusetts, United States-based company “General Electric” announced the successful acquisition of Boston, United States-based imaging company “BK Medical”.

Key Takeaways from the Angio Suites Market Report Study

• Market size analysis for current angio suites market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the angio suites market.
• Various opportunities available for the other competitors in the angio suites market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current angio suites market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for automated external defibrillator market growth in the coming future?

Target Audience who can be benefited from this Angio Suites Market Report Study

• Angio suites product providers
• Research organizations and consulting companies
• Angio suites-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in angio suites
• Various end-users who want to know more about the angio suites market and the latest technological developments in the angio suites market.

Frequently Asked Questions for the Angio Suites Market:

1. What are angio suites?

• The angio suite is an examination room where complex surgical procedures like angiography, stenting, bypass surgery, etc. are performed with high precision. It helps in the detection and observation of damaged blood vessels present in different organs, helping in the diagnosis and treatment of conditions like aneurysms, vascular stenosis, coronary atherosclerosis, etc.

2. What is the market for angio suites?

• The angio suites market was valued at USD 2.18 billion in 2023, growing at a CAGR of 5.75% during the forecast period from 2024 to 2030 to reach USD 3.05 billion by 2030.

3. What are the drivers for the angio suites market?

• The angio suites market is observing substantial market growth primarily owing to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation, peripheral artery disease (PAD), and coronary artery disease (CAD), innovative product developmental activities by leading companies, and the rising geriatric population that are expected to escalate the overall growth of the angio suites market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the angio suites market?

• Some of the key market players operating in the angio suites market include Siemens Healthineers, Koninklijke Philips N.V, Lam Vascular and Associates, Hitachi, Ltd., ESAOTE SPA, IMRIS, Onex Corporation, Canon Inc., 3D Systems, Inc., GE HealthCare, Shimadzu Corporation, GIMIAS, FUJIFILM Holdings Corporation, Hologic, Inc., Planmeca, Mindray Medical International Limited, ZEISS International, Guerbet, Surgical Science, B.Braun Melsungen AG, and others.

5. Which region has the highest share in the angio suites market?

North America is expected to dominate the overall angio suites market during the forecast period from 2024 to 2030. This can be attributed to several factors including the high prevalence of coronary artery disease and other heart conditions, along with associated risk factors for cardiovascular disorders, combined with significant advancements in product development and regulatory approvals that are acting as key factors contributing to the growth of the angio suites market in the North America region during the forecast period from 2024 to 2030.


This product will be delivered within 2 business days.